Transforming IBD Care

Gain a multidisciplinary perspective on treating inflammatory bowel diseases (IBD). Join health care professionals and researchers at the Crohn’s & Colitis Congress® for the premier conference on IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon. See you there on January 23–25, 2020 at the Austin Convention Center, Austin, Texas.

Dates to Remember

Discounted Registration Deadline: Wednesday, December 11

Abstract Notifications: Friday, December 6

Late-Breaking Abstract Submission Opens: Monday, December 16

Late-Breaking Abstract Submission Deadline: Friday, December 20


Crohn’s & Colitis Congress Chairs

David T. Rubin, MD, AGAF

Chair, Organizing Committee
University of Chicago

Uma Mahadevan, MD, AGAF

Co-Chair, Organizing Committee
University of California, San Francisco

Keynote Speaker

Helene Langevin, MD

Director, National Center for Complementary and Integrative Health National Institutes of Health

Supporting Organizations

The 2020 Crohn’s & Colitis Congress is supported by educational grants from:

Endorsed By

The 2020 Crohn’s & Colitis Congress is endorsed by:

Media Partners

The 2020 Crohn’s & Colitis Congress is partnered with:

Building on the success of this year’s inaugural Crohn’s & Colitis Congress™, the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are pleased to announce the second annual Crohn’s & Colitis Congress. Be sure to save the date.

February 7-9, 2019 at the Bellagio in Las Vegas

Gain a multidisciplinary perspective on treating IBD. Join IBD health care professionals to network, learn from each other, and collaborate in transforming IBD patient care.

By bringing all audiences together to learn from each other, the Congress embodies how IBD research and patient care needs to be approached – it is not “one-size-fits-all” and it requires collaboration from a variety of health practitioners.

Be sure to visit this website in the future for more details. Registration will open on June 27, 2018

If you attended the 2018 Crohn’s & Colitis Congress, you can continue to use the mobile app after the meeting to view session presentations (that presenters agreed to publish), abstracts and more.

To claim CME for the Congress, please complete the CME Request Form. Your CME certificate will be emailed to you within a week of completing the form.


The Crohn's & Colitis Congress is supported by educational grants from AbbVie Inc., Celgene Corporation, Gilead Sciences, Inc., Merck & Co., Inc., Nestlé Health Science, Pfizer, Salix Pharmaceuticals, Shire Plc. and Takeda Pharmaceuticals U.S.A., Inc.

Endorsed By: